Startup Stage: Project ⎢ TRL4 / CRL1

Value Proposition: A biotech platform to help healthcare innovators with limited access to high-quality peptide-target interaction data by generating structured, high-throughput datasets across diverse targets with a proprietary system that unlocks next-gen applications in drug discovery, enzymatic design, vaccines, and diagnostics

Product: Materials

Market: Health

IP: 3 Patents

Founders (ext.): Commercial, -- │ Technical, Cesar Pascual Garcia & Janwa El Maiss

Contact (int.): Research, Cesar Pascual Garcia │ Ventures, Alex Godlewski

Revenue: --

Funding: Grant (EIC) │ €3M raised in total